
Keywords: کربوکسی تحمل; ACM; astrocytic conditioned medium; AD; Alzheimer's disease; AIDS; acquired immunodeficiency syndrome; ALS; amyotrophic lateral sclerosis; Carboxy-PTIO; 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide; CBB; Coomassie brilliant blue; CR